1. Home /
  2. Mad Money

Mad Money

Eli Lilly Is Going Strong: Here's How to Play It

Let's check out the LLY charts amid FDA approval of the company's Alzheimer's drug.

Carvana's Shares Are Making a U-Turn Near the Highs

Let's kick the tires and review the charts and indicators.

Vista Outdoor's Charts Target Higher Share Prices on the Horizon

The technical signals for the maker of outdoor recreational equipment are bullish.

Everi-thing Cramer Said About EVRI Is Correct

Shares of Everi could grind a little higher from here, but here's what investors should do now.

Expect Energy Firm Stem to Rally From Here

Here's where aggressive traders could go long.

Box Is Poised for an Important Breakout

Let's review the charts and indicators.

Feelin' the Love for the Charts of Game Developer AppLovin

There isn't much technical history for the company that went public in the spring, but what is there is positive for this Jim Cramer fave.

Magna International Is Not a Great Opportunity Right Now

MGA's charts show it could correct further in time and price.

GlaxoSmithKline Needs More Positive Developments Before Investing

Here's what Jim Cramer expects to hear from GSK at this week's investor meeting.

XPO Logistics Should Soon Resume Its Advance

Aggressive traders could probe the long side of XPO.